About JBA

Profile of Japan Bioindustry Association

HistoryMembers

Board of Directors

JBA’s roots date back to Shusei Kyokai(the Distilled Spirits Institute) established in 1942.
Its name, after being changed to theJapanese Association of IndustrialFermentation, was renamed as Japan Bioindustry Association (JBA) in1987.

Corporate members: 227 companies(pharmaceutical, food, chemical, cosmetic and machinery companies)
Public members: 114 organizations
Individual members: approx. 600(university and corporate researchers)

Chairman
Sakayu Shimizu
Professor Emeritus, Kyoto University
President
Osamu Nagayama
Chairman & CEO,
Chugai Pharmaceutical Co., Ltd.
Executive Director
Yoshiaki Tsukamoto

AccessJapan Bioindustry Association
Grande Bldg. 8F,
26-9 Hacchobori 2-chome, Chuo-ku,
Tokyo 104-0032, Japan
Tel +81-3-5541-2731 Fax +81-3-5541-2737
URL http://www.jba.or.jp/
September 2016

AdvancedBiotechnology
Agora

VisionDiscovery of Seeds/Commercialization

16 years have passed in the 21st century, which is said tobe the Era of Biotechnology. During this period, not only
has traditional biotechnology deepened, but also a variety of new technologies based on molecular biology andcell biology has emerged. Although the shift is gradual,
these technologies are taking root in various industries
and are making a large impact on businesses dealing
with the environment, food supply, chemical industry,healthcare, and medicine. However, many of these technologies are still in the preparatory stage, and there is asense that we still must overcome a big hurdle before thebioindustry becomes a core industry in true sense.
Biotechnology employs functions unique to living thingsand has unexpectedness and ambiguity as prominent
characteristics. Many things go against our wishes orexpectations, and there are many things we do not understand well enough. Furthermore, at the leading edgeof R&D, there is rapid growth of new technologies competing for priority rights, just like the growth point of anew bud. However, it usually takes time for new technologies to be actually implemented, just as it takes time forsprouts to grow up to be big trees. We need to be awarethat such new technologies cannot reflect present needs
immediately and so require social understanding andpeople’s patience. It may be the time to accumulate scientific facts and build up "Bio Power", the ability for society
as a whole to utilize the knowledge of biotechnology.
Fortunately, the core technologies of Japan, such as fermentation and plant breeding, are being broadly applied
to a wide range of diverse industrial fields, and retain
competitiveness in new technological fields that are rapidly growing in the advanced countries. If we employ thefull potential of Japanese "Bio Power", we may be able tolead the world in promising directions. As we progress
further in this new Era, I believe that the roles of the Japan
Bioindustry Association (JBA) will become increasingly important.
Sakayu Shimizu, Ph.D.
Chairman,Japan Bioindustry Association

PolicyProposals andDialogues
Promotion ofbio-related policies

Cooperation of the government,industry, and academia
lSeminars for providing information
on advanced biotechnology
lStudy group activities
lR&D project design

lCreation of a Bioeconomy
Vision for 2030
lPolicy dialogues(such as adaptation toNagoya Protocol)

Promotion ofOpen Innovation

JBA’s 5 Actions
MissionWe build foundations ofbioindustry development and makeadvances in people’s lives
Solving issues faced by all mankind requires a strategy
and policy to utilize outcomes of fundamental researchof Japan. One important mission of JBA is to promote revision of regulations on scientific grounds and propose
strategies requiring the collaboration of industry, academia, and government.
We also help establish collaborative structures involving international bio-related institutions to solve crucial
global scale problems such as climate change and loss ofbiodiversity.
Science is developing at a faster rate, and open innovation is essential to help accelerate commercialization.
We provide opportunities to strengthen collaboration
among companies and academia by holding an annual
event, BioJapan.
JBA organizes a basic framework for the growth of bioindustry and contributes to improvements in all of ourdaily lives.

Bioindustry
Infrastructure
Establishment
Enhancement ofworking group activities
lAcceleration of new technology
implementation
lIntellectual property committee activities
lBiotechnology humanresources development
lRaising awareness of access tooverseas genetic resources
and benefit sharing

GlobalNetworkingand Framework
CreationTransmitting overseas
biotechnology news andbio-related events
lGlobal cooperation-related
seminars, BioJapanlMembers' communicationCooperation withcompanies, support ofbusiness ventures
lBusiness seminars
lSupport of collaboration
among bio-related parties

Overseas bio-organizations havingagreements with JBA

l…JBA members (31 organizations as of June 2016) l…Overseas biotechnology organizations with which JBA has written agreements (as of June 2016)

Asia
EuropelIreland lUK lEstonia
lthe Netherlands lAustria
lSweden lSpain lCatalonia (Spain)lthe Czech Republic lDenmark
lGermany lFrance lLithuania
lScotland (UK) lFlanders(Belgium)
lWallonia (Belgium)lBrussels(Belgium)lSwiss Biotech Association(since 2005)
lRussian Biotechnology Society 		(since 2009)lCLIB2021(Bioclusters of the Rhein Region)/Cluster Bioindustrielle 			
Biotechnologie (since 2009)lDECHEMA (since 2010)
lMedicon Valley Alliance(Denmark/Sweden) (since 2012)
lSwedenBIO (since 2013)
lLife Science Austria (since 2013)
lEurasante (France) (since 2014)lAlsace Biovalley (France)(since 2014)
lEnterprise Lithuania (Lithuania) 		
(since 2015)

lMalaysia
lShanghai Biopharmaceutics 		
Industries Association 			(since 2005)
lKoreaBIO (since 2012)
lMedical and Pharmaceutical 		Commercial Association, 		
All-China Federation of Industry 		and Commerce (since 2012)
lTaiwan Bio Industry Organization(since 2012)
lNew Taipei City Bio Technology 		Alliance (since 2015)

OceanialAustralia lQueensland (Australia)lVictoria (Australia)
lAusBiotech (since 2013)
lLife Sciences Queensland(since 2015)

CanadaUnited StateslCanada lAlberta lOntario
lQuebec lBritish Columbia

lU.S. lIowa lGeorgia
lNorth Carolina lPennsylvanialBIO (since 2004)
lBiocom (since 2014)

Japanese bio-venturecompanies and bio-clusters
in relation to JBA
lKumamoto Industrial SupportFoundation

lFoundation for Biomedical 		Research and Innovation
lKinki Bio-Industry Development 		Organization
lSenri Life Science Foundation

lKurume Research Park

Creation ofInternational Network
JBA provides international information on biotechnology andbioindustry in cooperation with member companies,universities, and the government.

lHokkaido Bio-Industry Association
lNorthern Advancement Center
for Science & Technology
lHokkaido Association for
Bio-BusinesslKihara Memorial Yokohama 		Foundation for The
Advancement of Life Sciences
lOsaka Bio Headquarters
lShikoku Industry & Technology
Promotion Center
lOkinawa Industry Promotion
Public Corporation

lThe Shizuoka Organization for 		
Creation of Industries Pharma 		
Valley CenterAcceleration ofOpen Innovation

Policy Proposal ofJapan’s Bioeconomy Vision
Asia’sNo.1

JBA provides opportunities to help thedevelopment of biotechnology and industry.

PartneringEvent!

JBA together with JABEX created the “Bioeconomy Visionof Japan for 2030: Bioindustry’s Contribution to Enhance
Adaptation to the Changing World”, aiming to achieve a40 trillion yen new market. This Vision covers global environment issues, international policy and biotechnologicaltrends in health, manufacturing, agriculture, and foodbusiness sectors.

The Vision describes key technology that is required, collaboration among government, industry and academia,
an innovation ecosystem, human resource development,
communication to society, and contributions to the restof the world. JBA is working on sharing these ideas withrelevant people in order to realize the Vision.

Bioeconomy Vision of Japan for 2030
Bioindustry’s social contribution tocreation of new key industry and provide
solutions on global issues

Exhibition

Partnering

Manufacturing/
Environment/Energy

Seminar

Health/medicine

Shift to sustainable
manufacturing
and new industry
generation

Achievement of healthy
longevity by disruptive
innovation

Environment/
EnergyFoods

Agri./Forest/
Fishery/Foodstuff
Acceleration ofinvolvement of industries
to agriculture and foodexport promotion

Diagnosis/
Medical devices

Collaborative research

Support for Internal Bio-Venture
Companies and Bio-Clusters

Health care

Licensing in and out
Medicine/Medical

Economical benefit (market size):
40 tril yen, GDP: 20 tril yen,
Employment 80 mil. jobs

Business Partnerships
Creating innovation in fusional areas

JBA holds the partnering bio event BioJapan and theRegenerative Medicine Japan as key business platforms.

Research tools

Giving support to bio-ventures,and collaborative activities
among bio-related parties
Exchanges and cooperation amongindustry, academia and government
are promoted through informationexchanges and cooperative activities
utilizing JBA’s network linking biotechnology organizations and clusters all over Japan.

Conference ofbio-related parties
The conference considered thestrengthening of the network linking the primary organizations forindustry-government-academia cooperation in biotechnology in all theregions of Japan. It shares information among these organizations, andfuture guidelines, with the aim ofestablishing a system where theseorganizations cooperate closely.

Biocluster summit
Biotechnology organizations fromvarious countries gather in Japan tohave deep discussions on the spiritof entrepreneurship, securing corehuman resources, and the importance of the formation of networks
among companies and among entrepreneurs.